Submit Deal

ADMARE BIOINNOVATIONS

Deals Overview

Total Deals4

Valued Deals4

Total Value£ 152 M

Avg. Deal Size£ 38 M

Market Context

Senior Management

Gordon C. McCauley
President and CEO
Frédéric Lemaître Auger
Managing Partner

Senior Management

Gordon C. McCauley
President and CEO
Frédéric Lemaître Auger
Managing Partner

Sort

10 May 2022|Canada|Biotechnology

Target: DOMAIN THERAPEUTICS

Bidder: THEODORUS

20 Service Providers

7 Target | 13 Bidder

29 Dealmakers

11 Target | 18 Bidder

£ 33 M

Value

17 Oct 2022|Canada|Biotechnology

Target: INVERSAGO PHARMA

Bidder: NEW ENTERPRISE ASSOCIATES (NEA)

10 Service Providers

3 Target | 7 Bidder

19 Dealmakers

12 Target | 8 Bidder

£ 62 M

Value

24 Oct 2024|United Kingdom|Biotechnology

Target: EPITOPEA

Bidder: INVESTISSEMENT QUEBEC

6 Service Providers

2 Target | 4 Bidder

9 Dealmakers

3 Target | 6 Bidder

£ 23 M

Value

02 Dec 2024|Canada|Biotechnology

Target: KISOJI BIOTECHNOLOGY

Bidder: LUMIRA VENTURES

7 Service Providers

3 Target | 4 Bidder

15 Dealmakers

6 Target | 9 Bidder

£ 32 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy